Does INFLIXIMAB, RECOMBINANT Cause Infection? 6 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Infection have been filed in association with INFLIXIMAB, RECOMBINANT. This represents 2.4% of all adverse event reports for INFLIXIMAB, RECOMBINANT.
6
Reports of Infection with INFLIXIMAB, RECOMBINANT
2.4%
of all INFLIXIMAB, RECOMBINANT reports
3
Deaths
1
Hospitalizations
How Dangerous Is Infection From INFLIXIMAB, RECOMBINANT?
Of the 6 reports, 3 (50.0%) resulted in death, 1 (16.7%) required hospitalization.
Is Infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB, RECOMBINANT. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB, RECOMBINANT Cause?
Pneumocystis jirovecii pneumonia (29)
Off label use (21)
Infusion related reaction (18)
Histoplasmosis disseminated (16)
Tuberculosis (15)
Lupus-like syndrome (13)
Pulmonary tuberculosis (12)
Drug ineffective (11)
Pneumonia (11)
Crohn's disease (9)
What Other Drugs Cause Infection?
ADALIMUMAB (11,552)
METHOTREXATE (10,406)
ETANERCEPT (10,379)
RITUXIMAB (9,575)
ABATACEPT (7,821)
TOCILIZUMAB (7,349)
PREDNISONE (6,334)
TOFACITINIB (6,332)
INFLIXIMAB (6,122)
CERTOLIZUMAB PEGOL (5,954)
Which INFLIXIMAB, RECOMBINANT Alternatives Have Lower Infection Risk?
INFLIXIMAB, RECOMBINANT vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN
INFLIXIMAB, RECOMBINANT vs INFLUENZA VIRUS VACCINE
INFLIXIMAB, RECOMBINANT vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B
INFLIXIMAB, RECOMBINANT vs INGENOL MEBUTATE
INFLIXIMAB, RECOMBINANT vs INLYTA